PolyPid Ltd reports results for the quarter ended September 30 - Earnings Summary

Polypid

13/11/2024 15:25

* PolyPid Ltd  PYPD.OQ  reported quarterly adjusted earnings
of
$1.22​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-3.40.  The mean expectation of four analysts for the
quarter was for a loss of 100 cents per share. Wall Street
expected results to range from $-1.12 to -88 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * PolyPid Ltd's reported EPS for the quarter was $1.22​.
    * The company reported quarterly net income of $7.76
million.
    * PolyPid Ltd shares had risen by 1.7% this quarter and
lost 7.9%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 11.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for PolyPid Ltd is
12.00 
This summary was machine generated from LSEG data November 13 at
03:25 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.00          1.22           Beat
 Jun. 30 2024      -1.30          -1.25          Beat
 Mar. 31 2024      -1.41          -1.37          Beat
 Dec. 31 2023      -3.58          -3.97          Missed